Please provide your email address to receive an email when new articles are posted on . Women with type 2 diabetes who are at risk for heart disease had a 30% reduction in adverse cardiovascular ...
Objective: In order to assess the long-term (12 months) efficacy and safety of fenofibrate administered with simvastatin in the treatment of primary mixed hyperlipidaemia, we conducted a study that ...
Use of the cholesterol-lowering drug fenofibrate had a modest but statistically significant association with reduced risk of vision-threatening diabetic retinopathy (VTDR), according to results of a ...
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that the blood-fat lowering drug fenofibrate is as effective in women with type 2 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with type 2 diabetes had a 36% lower risk for ...
kidney cross section Researchers assessed the incidence and potential risk factors for the development of fenofibrate-associated nephrotoxicity in patients with gout. Fenofibrate-associated ...
Fenofibrate Found Safe in Diabetes With Renal Impairment Long-term daily use of fenofibrate is beneficial for patients with type 2 diabetes and moderate renal impairment and is not associated with an ...
Treatment with fenofibrate in individuals with type 2 diabetes mellitus reduces the need for laser treatment for diabetic retinopathy (DR), conclude authors of an Article published early Online and in ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. FENOFIBRATE VIATRIS contains the active ingredient fenofibrate.
(HealthDay News) — A combination of testosterone and fenofibrate may offer men with high cholesterol and late-onset hypogonadism the most cardiometabolic benefit, according to a study published online ...
The effects of combined fibrate and statin treatment (simvastatin 10mg plus fenofibrate 200mg) on plasma lipid and lipoprotein (TC, TG, LDL-C, HDL-C) levels at baseline and after 3, 6 and 12 months, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results